CurrentCardio
Get Weekly

Topic · page 28 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,081–1,120 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. J Am Coll Cardiol

    Heart Failure Care and Outcomes After Private Equity Acquisition of U.S. Hospitals

    Cohort study

  2. Eur J Heart Fail

    Long-Term Efficacy of Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy by National Amyloidosis Centre stage

    Secondary analysis

  3. JACC Heart Fail

    Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials

    Meta-analysis

  4. Eur J Heart Fail

    Cardiac Resynchronization Therapy for Enabling Guideline-Directed Medical Therapy Optimization in Heart Failure

    Cohort study

  5. JACC Heart Fail

    Association of the 2018 U.S. Heart Allocation Policy Change and the Survival Benefit of Heart Transplantation

    Cohort study

  6. Eur J Heart Fail

    Mechanical Unloading is Accompanied by Reverse Metabolic Remodelling in the Failing Heart: Identification of a Novel Citraconate-Mediated Pathway

    Mechanistic study

  7. Eur J Heart Fail

    Sodium Chloride Versus Glucose Solute as a Volume Replacement Therapy for More Effective Decongestion in Acute Heart Failure (SOLVRED-AHF): A Prospective, Randomized, Mechanistic Study

    Randomised controlled trial

  8. JAMA Cardiol

    Artificial Intelligence–Enabled Prediction of Heart Failure Risk From Single-Lead Electrocardiograms

    Cohort study

  9. JAMA Cardiol

    Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial

    Randomised controlled trial

  10. Eur J Heart Fail

    Insights into the European Heart Failure Epidemiology

    Cross-sectional study

  11. Eur J Heart Fail

    Global Heart Failure Epidemiology Versus Enrolment in Pivotal Trials: A Formidable Mismatch

    Cross-sectional study

  12. JACC Cardiovasc Imaging

    Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography/Computed Tomography

    Diagnostic or prognostic study

  13. Eur J Heart Fail

    Albuminuria as a Diagnostic Criterion and a Therapeutic Target in Heart Failure and Other Cardiovascular Disease

    Research article

  14. J Am Coll Cardiol

    Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy

    Secondary analysis

  15. Eur J Heart Fail

    Clinical and Financial Implications of Inpatient and Outpatient Management of Worsening Heart Failure

    Cohort study

  16. Eur J Heart Fail

    Longitudinal Blood Pressure and Cardiovascular Outcomes in Heart Failure: An Individual Patient Data Pooling Analysis of Clinical Trials

    Meta-analysis

  17. Circulation

    Genotype-Specific Outcomes of Desmosomal Cardiomyopathies

    Cohort study

  18. JACC Cardiovasc Interv

    Prognostic Value of Microvascular Function in Takotsubo Syndrome: A Pooled Analysis of Individual Patient Data

    Meta-analysis

  19. Eur J Heart Fail

    Home-based Urinary Sodium Monitoring via Point-of-Care Testing for Personalized Diuretic Titration in Heart Failure Management: The EASY-STOP study

    Cohort study

  20. Eur J Heart Fail

    Incident Heart Failure is Common and Underrecognized in Patients with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease

    Cohort study

  21. Eur Heart J

    Cardiologist follow-up and improved outcomes of heart failure: a French nationwide cohort

    Cohort study

  22. Eur Heart J

    Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial

    Secondary analysis

  23. Eur J Heart Fail

    Anaemia in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial

    Secondary analysis

  24. JACC Cardiovasc Imaging

    The Cardiovascular Magnetic Resonance Phenotype of Lamin Heart Disease

    Cohort study

  25. Eur J Heart Fail

    Effect of Pulmonary Artery Pressure-Guided Management on Outcomes of Patients with Heart Failure Outside Clinical Trials: A Systematic Review and Meta-Analysis of Real-World Evidence with the CardioMEMS Heart Failure System

    Meta-analysis

  26. J Am Coll Cardiol

    Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure With Preserved Ejection Fraction

    Cross-sectional study

  27. JACC Heart Fail

    Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study

    Secondary analysis

  28. Eur J Heart Fail

    Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC

    Guideline or statement

  29. Eur J Heart Fail

    Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESC

    Guideline or statement

  30. Eur J Prev Cardiol

    Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy

    Case-control study

  31. JAMA Cardiol

    Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health Study

    Cohort study

  32. JAMA Cardiol

    Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration

    Cohort study

  33. JAMA Cardiol

    Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy

    Cohort study

  34. Eur J Prev Cardiol

    Features of T wave inversion and diagnosis of cardiomyopathy: relevance for a cardiac screening programme in young individuals

    Cohort study

  35. JACC Heart Fail

    LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered Breathing

    Secondary analysis

  36. JACC Heart Fail

    The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy

    Cohort study

  37. J Am Coll Cardiol

    Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy: HELIOS-B

    Secondary analysis

  38. Eur J Heart Fail

    The Efficacy of Finerenone on Hierarchical Composite Endpoint Analysed Using Win Statistics in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF

    Secondary analysis

  39. Eur J Heart Fail

    Integrated Role of Cardiac Magnetic Resonance and Genetics in Predicting Left Ventricular Reverse Remodelling in Dilated and Non-Dilated Cardiomyopathy

    Cohort study

  40. Eur J Prev Cardiol

    Risk calculator of multimorbid risk of rehospitalization and death from heart failure: including the contribution of the gut microbiome

    Diagnostic or prognostic study

All 1,928 Briefs in ExploreShowing Briefs 1,081–1,120 of 1,928, newest first